INTRODUCTION
The pyrazolo [1,5-a] [1, 3, 5] triazine (5-aza-9-deazapurine) heterocyclic system is an isostere of purine 5. Two-bond formation (4+2) through cyclization of 5-aminopyrazoles having carbon atom at N1 with reagents introducing C-N fragment.
6. Two-bond formation (4+2) through cyclization of pyrazoles having N-C appendage at C3(5) with reagents introducing C-N fragment.
7. Two-bond formation (5+1) through cyclization of 5-aminopyrazoles having C-N appendage at N1 with one carbon atom.
8. Two-bond formation (5+1) through cyclization of pyrazoles having N-C-N appendage at C3(5) with one carbon atom.
9. One bond formation through intramolecular cyclization of 5-aminopyrazoles having C-N-C appendage at N1.
One bond formation through intramolecular cyclization of pyrazoles having N-C-N-C appendage at
C3 (5) . The condensation of 3(5)-phenylaminopyrazoles (1) with two equivalents of formaldehyde and one equivalent of primary amines was reported to proceed regioselectively affording 1,2,3,4-tetrahydropyrazolo [1,5-a] [1, 3, 5] triazines (2) (Scheme 2). 3 It should be mentioned that using of However, the type of substituent at the exocyclic nitrogen atom also played a role in the regioselectivity of ring closure. Thus, the annelation of tetrahydropyrimidine ring was observed when 3(5)-methylaminopyrazoles were used as starting materials. Scheme 3
Three-bond formation (3+2+1) through cyclization of 3(5)-aminopyrazoles with reagents
introducing C-N fragment and one carbon atom.
The reaction of 3(5)-aminopyrazole (5a) and aryl cyanates in acetone was reported to afford 4-aryloxy-2,2-dimethyl-2,3-dihydropyrazolo [1,5-a] [1, 3, 5] triazines (6) (Scheme 4). 5 When DMF was used as a solvent in the reaction of 5a with phenyl cyanate, unstable adduct 7 was obtained. It was reported that the reaction of 3(5)-aminopyrazole (5a) with ethyl N-benzoylimidates (8a) afforded 2,4-diarylpyrazolo [1,5-a] [1, 3, 5] triazines (11) (Scheme 5). 8 The regioselectivity of this reaction was not discussed in the original paper 8 even though formation of the isomer 12 would be preferred over 11b
because of higher nucleophilicity of exocyclic nitrogen atom of 3(5)-aminopyrazole (5a). In view of this fact, more rational mechanism of similar heterocyclization was proposed in the reaction of the substituted The reaction of 3(5)-aminopyrazoles (5) with methyl N-aroylthioacetimidates (8b) effected annelation to 4-aryl-2-methyl-1,3,5-triazine ring, exclusively (Scheme 7). 10 The structure of the product 15 (R 1 = CHEt 2 , R 2 = C 6 H 3 Cl 2 -2,4) was supported by X-ray crystallography data.
Similarly, the 2,4-diarylpyrazolo [1,5- . 12 The structural assignments were confirmed using NMR data, including HMBC experiment for 21b. The annelation of the 2-aryl-4-aminoalkyl-1,3,5-triazine ring onto 3(5)-aminopyrazoles (5) using N-substituted methyl thioimidates 22 (Scheme 10) was reported 13 
Scheme 12
The preparation of 4-aminopyrazolo [1,5-a] [1, 3, 5] triazine (5-aza-9-deazaadenine, 30a) from 3(5)-aminopyrazole (5a) using ethyl N-cyanoformimidate (9a) (Scheme 13) was reported. 15 In order to confirm the structure of 30a, an independent synthesis of this compound was also performed. 
Scheme 14
It was reported that ethyl N-carbethoxyacetimidate (10a) was an effective reagent for the annelation of the 2-methyl-4-oxo-1,3,5-triazine ring onto 3(5)-aminopyrazole 5d (Scheme 15). 21 The product of this reaction, compound 34 was claimed to be an intermediate in the synthesis of the compounds with high affinity to 5-HT 6 receptors (vide infra Section 6). The regioselectivity of the ring closure was established by the preparation of 37 via an alternative synthetic pathway (vide infra Scheme 63) 22 and X-ray crystallographic study of 37b,d. 23 The isolation of intermediate 36 was shown to be possible when the reaction was carried out at room temperature. 
Scheme 17
The reaction of 3(5)-aminopyrazole 5f with cyanoguanidine (38) Scheme 18
The reaction of 3(5)-aminopyrazoles (5) with cyanoguanidine (38) has a long history, and it was found to be a good tool for the preparation of a variety of the 2,4-diaminopyrazolo [1,5- . 24 It should be noted that no data was provided to support the regioselective formation of 46a. The reactions were reported to proceed under basic catalysis (potassium carbonate, 29 triethylamine, 30 diethylisopropylamine 31 or piperidine [32] [33] [34] [35] ) or high temperature (180 °C) 36 affording regioisomeric structures 49 [31] [32] [33] [34] [35] with 2-amino and 4-methylthio groups at 1,3,5-triazine nucleus or vice versa 51. [29] [30] [31] 36 Only one of the isomers (49 or 51) was isolated from the reactions and their mixture was never obtained.
However, no special study on the effects of substituents at pyrazole nucleus, reaction conditions or type of catalyst is currently available. Furthermore, no unequivocal evidence for the assigned structures 49 and 51 has been reported despite a large number of the compounds synthesized by different groups. [29] [30] [31] [32] [33] [34] [35] [36] Obviously, further investigation of the reaction is necessary to clarify the regiochemistry of the heterocyclization.
Similarly, the structure of tricyclic 1,3,5-triazines 53 assigned 37 to products from the reaction of 3-aminopyrazole [3,4-b] pyridines (52) with dialkyl N-dithiocarbonimidate (9b) (Scheme 24) also required more detailed investigation since the regioselectivity of the reaction is uncertain. The ring closure carbonylation of 1-amidino-5-aminopyrazole (68b) with N,N'-carbonyldiimidazole was used for the preparation of 77a, which is 5-aza-9-deaza isostere of isoguanine (Scheme 36). 50 Using N,N'-thiocarbonyldiimidazole under similar conditions, thio analogue 77b was synthesized, but yield was lower. Scheme 36
The ring closure reactions of 5-amino-1-carbamoylpyrazoles (78) Diethyl carbonate, 49, 55, 57, 61, [79] [80] [81] [82] [83] [84] [85] [86] [87] N,N'-carbonyldiimidazole [86] [87] [88] and triphosgene 89 were used as carbonylating reagents in the syntheses of 79. This approach found an application for the preparation of compounds with valuable biological properties (vide infra Section 6). It was demonstrated that on heating in xylene or upon treatment with a base, (118) cyclized to produce 5-aza-9-deazahypoxanthine (79a) (Scheme 60). 15 The potassium carbonate promoted cyclization was used for the preparation of the C-nucleosides viz. an isostere of inosine and its α-anomer. , 55% (139c)
N-carbethoxy-N′-(3(5)-pyrazolyl)formamidine

139
Scheme 72
SYNTHESIS VIA RING TRANSFORMATION REACTIONS
In this synthetic category, three types of reactions were identified. First reaction can be also formally Scheme 74
The 1,2,3-triazine to pyrazole (144 to 44) ring transformation was also reported (Scheme 75). 106, 107 In these reactions, the hydrazines 136 or azides 137 were proposed to be intermediates (cf. Scheme 70) . 
Enzyme inhibitors
The last steps of purine catabolism involve the enzyme xanthine oxidase (XO), which oxidizes hypoxanthine to xanthine and eventually to uric acid. Therefore, this enzyme is a good target to control hyperuricemia, particularly in the treatment of gout. In the search of new inhibitors of XO, Robins et al. 55 identified 8-phenyl-5-aza-9-deazahypoxanthine (79b, Figure 3) as one of the leads in the study. This compound had more than three order activity as compared to unsubstituted 5-aza-9-deazahypoxanthine (79a).
Japanese research group 56,116,117 developed a very potent XO inhibitor BOF 4272 (145) (Figure 3 ), which
showed promising results in in vitro and in vivo studies [118] [119] [120] including experimental data on healthy human volunteers. 121 The BOF 4272 targets the main organs of uric acid production in human viz. liver and small intestine, thus significantly decreasing XO activity. It was found that BOF 4272 could also prevent cell necrosis by reducing the concentration of free radicals generated by xanthine oxidase. 122 The mechanism of XO inhibition by BOF 4272 was studied in detail 118, 119 and stereochemistry was found to play an important role in the activity of BOF 4272. The in vitro studies showed that both of the enantiomers were mixed type inhibitors, wherein (S)-(-)-enantiomer was much more potent than (R)-(+)-enantiomer ( Figure 3) . 118, 119 The stereoselectivity was also observed for the pharmacokinetic parameters and biotransformation of BOF 4272. [123] [124] [125] [126] [127] Considering these facts, the asymmetric syntheses of BOF 4272 were developed. Scheme 76
The pyrazolo[1,5-a] [1, 3, 5] triazines 149 with CDK2 inhibitory activity possess a wide range of substituents (R 2 -R 4 ), but they have some common restrictions for substitution at pyrazole ring (unsubstituted position 7) e.g. 149a 104 and 149b 96 ( Figure 4 ). The antiproliferative activity study showed that 149b was also active against human colon cancer cells. yield) . 57, 77, 132 In another study, 133 4-azido-7-phenylpyrazolo [1,5-a] [1, 3, 5] triazine (156) ( Figure 5 ) was found to be a potent irreversible inhibitor of calmodulin-dependent PDE (PDE1), but there was no investigation on selectivity. However, in the earlier report, 58 156 was found to possess α heart = 1.0 and α lung = 0 that may suggest some selectivity for PDE1 inhibition. 
99a
Figure 5
In the search of new potential PDE4 inhibitors for treatment of autoimmune and inflammatory diseases, two very potent compounds 161a,b were identified. 85 Both compounds were prepared via identical synthetic rout (Scheme 80) and possess similar substitution pattern. 
Scheme 83
The P2Y 1 -receptors are known to be involved in purinergic signaling, and they can be activated mainly by 62, 79, 80, 83, 84, [137] [138] [139] [140] At the last step, instead of the nucleophilic substitution of chlorine atom of 172, substitution of methylthio group of similar compounds was also applied. 71 The examples of biologically active 173 are presented in Figure 6 . 
Scheme 85
The DMP 696 (173a, Figure 6 ) was shown to be a noncompetitive antagonist with high affinity and selectivity for CRF 1 receptors. This compound (173a) exhibited high anxiolytic and antidepressant activities as well as good oral bioavailability and desirable pharmacokinetic properties. The DMP 696 (173a) is widely used as a reference compound and as an effective tool for the investigation of the role of CRF and its receptors in the behavior. The details on the mechanisms of action, side effects, pharmacokinetics and advantages of DMP 696 (173a) in comparison with other CRF 1 blocking agents can be found in the special reviews. 141, 142 The systemic effects of MJL 1-109-2 (173c, Figure 6 ) were investigated in detail using a battery of behavioral tests. 143 The radiolabeled [ 76 Br] MJL 1-109-2 was also synthesized and used for the autoradiographic visualization of CRF 1 receptors. 84 The preparation of the structurally different group of pyrazolo [1,5-a] [1, 3, 5] triazines (e.g. 15a, Figure 6) possessing high affinity to CRF receptor was carried out as outlined in Schemes 7 and 47. that are useful in asthma therapy, namely bronchodilator 145, 146 and antiallergic [145] [146] [147] activities, as well as low toxicity. Anti-inflammatory properties (not attributed to cyclooxygenase inhibition or mediator release) were also identified for LA 2851. 148 It was found that LA 2851 inhibited to some extent PDE, but this enzyme was not its primary target. The investigations on the mechanism of action of LA 2851
proposed that the lipoxygenase pathway was affected. The analogues (39 and 76) as well as derivatives (46) of LA 2851 and itself (39b) were prepared (Schemes 19, 21, 33, 35 and 88) and investigated as antiasthmatic agents using a variety of animal models and were also clinically tested in human. 24 There is no detailed information on the mechanism involved into the realization of biological activities of the compounds available. However, structural similarity and the observed pharmacological profile, particularly effects on CNS and cardiovascular system, may suggest that these compounds work as adenosine receptor antagonists. 
